What we offer — CRUK–MedImmune Alliance Laboratory
We’re here to help scientists realise the full potential of their discoveries and maximise the impact of breakthroughs made in the lab for patient benefit. Our team of antibody discovery experts can work with you to develop antibodies for therapeutic, diagnostic and research uses.
We provide all the expertise and facilities needed to develop antibodies against your target of interest, from the target validation to lead optimisation stages, all meeting the high quality standards required for drug development research.
If you’re working with novel targets in oncology, immunology or autoimmunity, we’re interested in talking to you.
CMAL provides a route for academic investigators to access world-class antibody drug discovery capabilities. The lab staff have established strong collaborative relationships with leading UK investigators and worked quickly and efficiently to generate antibody-based tools and lead candidates.
—Martin Glennie, Professor of Immunochemistry, University of Southampton
The CRUK-MedImmune Alliance Laboratory is an innovative collaboration between Cancer Research UK and MedImmune, based in Cambridge, UK. Scientists from both organisations work together in a standalone laboratory, which benefits from close proximity to MedImmune’s Cambridge facility.
If your research has identified potential molecular targets for antibody discovery, we'd love to work with you to translate your research. As part of a multidisciplinary team alongside our experts, you'll have the opportunity to help steer a project with impact for cancer patients, co-author on publications and patents, and bring new skills back to your lab.